Infinity Pharmaceuticals | INFI - Debt


Infinity Pharmaceuticals reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Amgen USD 54.59B 1.62B Sep/2025
AstraZeneca USD 32.63B 207M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Eisai JPY 236.67B 49.14B Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Grifols EUR 9.23B 626.05M Dec/2024
Incyte USD 40.41M 855K Dec/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
J&J USD 45.8B 4.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Plus Therapeutics USD 3.98M 372K Dec/2023
Roche Holding CHF 33.03B 1.41B Jun/2025
TG Therapeutics USD 245.34M 8.38M Sep/2025